Taken together, these studies utilizing human IBD samples fully support the view that activation of RIPK2 plays a pathogenic role in the development of both murine and human IBD by promoting the production of pro-inflammatory cytokines. This evidence concerns the gene RIPK2 and inflammatory bowel disease.